Richard A. Gonzalez

Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie Inc (ABBV), a global biopharmaceutical company that employs about 50,000 people worldwide and markets medicines in more than 175 countries. 

Gonzalez had spent 30 years with Abbott Laboratories (ABT) until AbbVie was spun off the parent firm. He served as President and Chief Operating Officer of Abbott before briefly retiring in 2007. He also held various senior leadership positions in Abbott’s medical products businesses, including President and Chief Operating Officer of the Medical Products Group; Senior Vice President and President of the former Hospital Products Division; Vice President and President of the Health Systems Division; and Divisional Vice President and General Manager for Diagnostics Operations in the United States and Canada. 

Gonzalez has been a long-standing leader in the greater Chicago community where he is a member of the Commercial Club of Chicago and represents AbbVie on their Civic Committee. He is also a member of the Business Roundtable, which is the only national organization representing exclusively CEOs of America’s leading companies.

AbbVie is a global, diversified research-based biopharmaceutical company positioned for success with a comprehensive product portfolio that has leadership positions across immunology, hematologic oncology, neuroscience, aesthetics and eye care. AbbVie uses its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the worlds most complex and serious diseases.

Gonzalez has an undergraduate degree from the University of Houston and a graduate degree from Miami University.